AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20496732 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Fluoxetine
Number of subjects: 84
Study 17623822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study 15667868 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily (OD)
Number of subjects: 360
Study 15667868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 15667868 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg OD
Number of subjects: 360
Study 12218722 — intervention group
Group type: EXPERIMENTAL
Intervention: E/NETA 0.25-mg group
Number of subjects: 120
Study 12218722 — intervention group
Group type: EXPERIMENTAL
Intervention: E/NETA 0.5-mg group
Number of subjects: 120
Study 12218722 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 120
Study 9795543 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical self-care book and education session
Number of subjects: 0
Study 9795543 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7893027 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine (0.2 mg)
Number of subjects: 7
Study 7893027 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine without epinephrine
Number of subjects: 7
Study 2667629 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone rubber cup
Number of subjects: 258
Study 2667629 — intervention group
Group type: COMPARATOR
Intervention: Metal vacuum extractor cups
Number of subjects: 258
Study 1091959 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl prednisolone acetate
Number of subjects: 0
Study 1091959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone acetate
Number of subjects: 0
Study 1091959 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study 31391073 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus Proactive Psychological Medicine (PPM)
Number of subjects: 3588
Study 31391073 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 3588
Study 28306329 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during office-based PNTP (Group I, n=50)
Number of subjects: 100
Study 28306329 — intervention group
Group type: COMPARATOR
Intervention: No music during office-based PNTP (Group II, n=50)
Number of subjects: 100
Study 25421369 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortobifemoral bypass surgery
Number of subjects: 78
Study 22669692 — intervention group
Group type: EXPERIMENTAL
Intervention: Fipronil spot-on formulation (26.8 mg a.i./kg)
Number of subjects: 0
Study 22669692 — intervention group
Group type: EXPERIMENTAL
Intervention: Fipronil spot-on formulation (13.4 mg a.i./kg)
Number of subjects: 0
Study 22669692 — intervention group
Group type: EXPERIMENTAL
Intervention: Fipronil spray formulation
Number of subjects: 0
Study 22669692 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated dogs)
Number of subjects: 0
Study 20394872 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital reactive hyperemia peripheral arterial tonometry (RH‐PAT) measured using Endo‐PAT2000 before cardiac catheterization.
Number of subjects: 140
Study 20394872 — intervention group
Group type: EXPERIMENTAL
Intervention: RH‐PAT index
Number of subjects: 140
Study 18714458 — intervention group
Group type: EXPERIMENTAL
Intervention: Determine HIV‐1/2
Number of subjects: 324
Study 18714458 — intervention group
Group type: COMPARATOR
Intervention: 4th generation ELISA (Vironostika HIV Uni‐Form II AG/Ab)
Number of subjects: 324
Study 15730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 200 mg
Number of subjects: 12
Study 12019586 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic dynamometry using a Biodex dynamometer (Multi joint system 2) at 60 degrees/second (5 repetitions), 120 degrees/second (10 repetitions), and 180 degrees/second (10 repetitions)
Number of subjects: 20
Study 12019586 — intervention group
Group type: EXPERIMENTAL
Intervention: Two consecutive individual measurements
Number of subjects: 20
Study 10343210 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with midazolam for upper GI endoscopy
Number of subjects: 10
Study 10343210 — intervention group
Group type: COMPARATOR
Intervention: No sedation (control group)
Number of subjects: 10
Study 10343210 — intervention group
Group type: COMPARATOR
Intervention: Sedation (control group) for patients without liver disease
Number of subjects: 10
Study 8542895 — intervention group
Group type: EXPERIMENTAL
Intervention: Talcid (hydrotalcite 1 g)
Number of subjects: 16
Study 8542895 — intervention group
Group type: EXPERIMENTAL
Intervention: Maalox (Mg‐Al‐hydroxide)
Number of subjects: 16
Study 8542895 — intervention group
Group type: EXPERIMENTAL
Intervention: Talcid
Number of subjects: 16
Study 8542895 — intervention group
Group type: EXPERIMENTAL
Intervention: Maalox
Number of subjects: 16
Study 1822599 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia (CSA) with 1.9 ml bupivacaine HCl 0.5%
Number of subjects: 33
Study 1822599 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural anesthesia (CEA) with 12.6 ml bupivacaine HCl 0.5%
Number of subjects: 33
Study 1822599 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia (CSA)
Number of subjects: 33
Study 1822599 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural anesthesia (CEA)
Number of subjects: 33
Study 7010157 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol (10 mg twice daily)
Number of subjects: 1884
Study 7010157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1884
Study 29676346 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey (H)
Number of subjects: 43
Study 29676346 — intervention group
Group type: COMPARATOR
Intervention: 2.5% Formal Saline (FS)
Number of subjects: 43
Study 25319752 — intervention group
Group type: EXPERIMENTAL
Intervention: Val homozygous adults
Number of subjects: 212
Study 25319752 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents
Number of subjects: 212
Study 25319752 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT Val158Met genotypes
Number of subjects: 212
Study 25319752 — intervention group
Group type: EXPERIMENTAL
Intervention: Network analyses
Number of subjects: 212
Study 23864516 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized pamphlets and home-exercise program
Number of subjects: 30
Study 23864516 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment contact group
Number of subjects: 30
Study 21933812 — intervention group
Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 74
Study 21933812 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation for change
Number of subjects: 74
Study 19878298 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical treatment with calcipotriol
Number of subjects: 0
Study 18417354 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun bed exposure (0.5 to 1 MED, twice per week for 4 weeks)
Number of subjects: 10
Study 18417354 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplement of 200 IU vitamin D (cod liver oil capsules)
Number of subjects: 10
Study 18417354 — intervention group
Group type: COMPARATOR
Intervention: No vitamin D supplementation
Number of subjects: 10
Study 16325084 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral fixation implant (Transfix; Arthrex) and interference screw (Arthrex) in the tibial tunnel
Number of subjects: 100
Study 16325084 — intervention group
Group type: COMPARATOR
Intervention: Extracortical fixation (EndoButton; Smith & Nephew) in the femur and bicortical screw and washer distal to the tibial tunnel
Number of subjects: 100
Study 12687466 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily calcitriol (10 ng/kg per day)
Number of subjects: 24
Study 12687466 — intervention group
Group type: COMPARATOR
Intervention: Intermittent calcitriol (35 ng/kg twice a week)
Number of subjects: 24
Study 10227453 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple drug regimen (TDR) with cyclophosphamide 200 mg/m2, methotrexate 20 mg/m2 once a week, and 6-mercaptopurine 50 mg/m2 daily
Number of subjects: 18
Study 10227453 — intervention group
Group type: COMPARATOR
Intervention: Oxymetholone (2 mg/m2/d)
Number of subjects: 18
Study 10227453 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy only
Number of subjects: 18
Study 9172009 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100‐mg slow‐release tablet every 8‐12 h)
Number of subjects: 131
Study 9172009 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine (0.2‐mg sublingual tablet every 6‐8 h)
Number of subjects: 131
Study 1765729 — intervention group
Group type: EXPERIMENTAL
Intervention: piracetam
Number of subjects: 60
Study 1765729 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 7159894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 51
Study 7159894 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 51
Study 31166287 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free T2347
Number of subjects: 242
Study 31166287 — intervention group
Group type: COMPARATOR
Intervention: BAK-preserved latanoprost-timolol fixed combination
Number of subjects: 242
Study 28115006 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimisation intervention to promote parent engagement in HENRY programme
Number of subjects: 144
Study 28115006 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimisation intervention
Number of subjects: 144
Study 26864655 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation and Therapeutic Exposure (BA-TE) delivered via Home-Based Telehealth (HBT)
Number of subjects: 232
Study 26864655 — intervention group
Group type: COMPARATOR
Intervention: Behavioral Activation and Therapeutic Exposure (BA-TE) delivered in person
Number of subjects: 232
Study 24313619 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine placental extract (PPE), 3 capsules per day for 24 weeks
Number of subjects: 44
Study 24313619 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine placental extract (PPE), 3 capsules per day
Number of subjects: 44
Study 24313619 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine placental extract (PPE), 6 capsules per day
Number of subjects: 44
Study 24313619 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 44
Study 22967105 — intervention group
Group type: EXPERIMENTAL
Intervention: telbivudine 600 mg
Number of subjects: 232
Study 22967105 — intervention group
Group type: COMPARATOR
Intervention: lamivudine 100 mg
Number of subjects: 232
Study 19005477 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-guided breathing (RESPeRATE), 15 min daily for 8 weeks
Number of subjects: 66
Study 19005477 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular treatment)
Number of subjects: 66
Study 17289891 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab (3 mg/kg for the first dose, then 1.5 mg/kg monthly for a total of four cycles)
Number of subjects: 11
Study 17289891 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 11
Study 16568918 — intervention group
Group type: EXPERIMENTAL
Intervention: P-ASA nerve block using CompuMed delivery system
Number of subjects: 21
Study 16568918 — intervention group
Group type: COMPARATOR
Intervention: Traditional multiple supraperiosteal (TMS) injections
Number of subjects: 21
Study 12512989 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest SpinBrush (experimental power toothbrush)
Number of subjects: 72
Study 12512989 — intervention group
Group type: COMPARATOR
Intervention: Colgate Wave (control manual toothbrush)
Number of subjects: 72
Study 12512989 — intervention group
Group type: COMPARATOR
Intervention: Colgate Plus (control manual toothbrush)
Number of subjects: 72
Study 10341999 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1
Number of subjects: 26
Study 10341999 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 26
Study 7727269 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative environment
Number of subjects: 179
Study 7727269 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive environment
Number of subjects: 179
Study 7727269 — intervention group
Group type: COMPARATOR
Intervention: Individualistic environment
Number of subjects: 179
Study 2250075 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied fluorescein gel
Number of subjects: 10
Study 7449597 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-planned menus for diabetic patients
Number of subjects: 0
Study 31084423 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based prevention intervention
Number of subjects: 0
Study 27325226 — intervention group
Group type: COMPARATOR
Intervention: AC group (anticoagulant group)
Number of subjects: 103
Study 27325226 — intervention group
Group type: COMPARATOR
Intervention: Warfarin group
Number of subjects: 103
Study 27325226 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran group
Number of subjects: 103
Study 27325226 — intervention group
Group type: COMPARATOR
Intervention: Apixaban group
Number of subjects: 103
Study 27325226 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban group
Number of subjects: 103
Study 27325226 — intervention group
Group type: COMPARATOR
Intervention: NOACs (non-vitamin K antagonist oral anticoagulants)
Number of subjects: 103
Study 26026705 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 intranasal units (IU) oxytocin
Number of subjects: 63
Study 26026705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 24145941 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence based medicine (EBM) workshop
Number of subjects: 148
Study 24145941 — intervention group
Group type: COMPARATOR
Intervention: Control group (other primary health care activities)
Number of subjects: 148
Study 20865424 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight youth during rest and exercise
Number of subjects: 146
Study 20865424 — intervention group
Group type: COMPARATOR
Intervention: Normal weight youth during rest and exercise
Number of subjects: 146
Study 20865424 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight youth at 5.6 and 8 kph
Number of subjects: 146
Study 19364421 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural pain management program (10 sessions)
Number of subjects: 95
Study 19364421 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 95
Study 17485550 — intervention group
Group type: EXPERIMENTAL
Intervention: Real‐time quantitative polymerase chain reaction analysis of antigen receptor gene rearrangements for detection of minimal residual disease (MRD)
Number of subjects: 284
Study 14870716 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 16
Study 11175930 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Powder Inhaler (DPI) - transparent Rotahaler
Number of subjects: 30
Study 11175930 — intervention group
Group type: COMPARATOR
Intervention: Metered Dose Inhaler (MDI) with spacer
Number of subjects: 30
Study 9594376 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenesis imperfecta patients with dentinogenesis imperfecta (DI)
Number of subjects: 88
Study 9594376 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenesis imperfecta patients with DI
Number of subjects: 88
Study 9594376 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenesis imperfecta type I patients with DI
Number of subjects: 88
Study 9594376 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenesis imperfecta type III and IV patients with DI
Number of subjects: 88
Study 9594376 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenesis imperfecta patients without DI
Number of subjects: 88
Study 9594376 — intervention group
Group type: COMPARATOR
Intervention: Osteogenesis imperfecta patients
Number of subjects: 88
Study 7737789 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric consultation intervention
Number of subjects: 106
Study 2691211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 0
Study 2691211 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 2691211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 804914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromoglycic acid tablets
Number of subjects: 24
Study 804914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30796109 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin therapy in pre-DM patients
Number of subjects: 258
Study 30796109 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemia (NG)
Number of subjects: 258
Study 30796109 — intervention group
Group type: COMPARATOR
Intervention: Pre-DM patients
Number of subjects: 258
Study 30796109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-DM metformin patients
Number of subjects: 258
Study 27511957 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention using a novel exercise park
Number of subjects: 0
Study 26332915 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate PBM therapy (2 min treatment using a 4 W laser beam, 171 J delivered)
Number of subjects: 80
Study 26332915 — intervention group
Group type: COMPARATOR
Intervention: Delayed PBM therapy (2 min treatment using a 4 W laser beam, 171 J delivered)
Number of subjects: 80
Study 23943845 — intervention group
Group type: EXPERIMENTAL
Intervention: Training during and after undergraduate studies
Number of subjects: 0
Study 23943845 — intervention group
Group type: EXPERIMENTAL
Intervention: Training after studies
Number of subjects: 0
Study 23943845 — intervention group
Group type: EXPERIMENTAL
Intervention: Training during undergraduate studies
Number of subjects: 0
Study 23943845 — intervention group
Group type: COMPARATOR
Intervention: 2005 vs 2010
Number of subjects: 0
Study 23943845 — intervention group
Group type: EXPERIMENTAL
Intervention: Training
Number of subjects: 0
Study 21724005 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 301
Study 21724005 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional intravenous anesthesia with lidocaine
Number of subjects: 301
Study 21724005 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional intravenous anesthesia with lidocaine and clonidine
Number of subjects: 301
Study 21724005 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary plexus block
Number of subjects: 301
Study 21724005 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of CRPS after CTR
Number of subjects: 301
Study 19465624 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedic practitioner (PP) scheme
Number of subjects: 0
Study 19465624 — intervention group
Group type: COMPARATOR
Intervention: Usual emergency care (control)
Number of subjects: 0
Study 16476941 — intervention group
Group type: EXPERIMENTAL
Intervention: SIB-1508Y (10 mg daily)
Number of subjects: 77
Study 16476941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 15459829 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance exercise
Number of subjects: 9
Study 15459829 — intervention group
Group type: COMPARATOR
Intervention: Control trial
Number of subjects: 9
Study 11908373 — intervention group
Group type: EXPERIMENTAL
Intervention: Battery-powered toothbrush (Colgate Actibrush)
Number of subjects: 0
Study 11908373 — intervention group
Group type: COMPARATOR
Intervention: Electric toothbrush (Braun Oral‐B Plaque Remover)
Number of subjects: 0
Study 9323924 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparotomy via the Rutherford‐Morrison incision (Group A)
Number of subjects: 56
Study 9323924 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy via right paramedian incision (Group B)
Number of subjects: 56
Study 8295604 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine tartrate (DHE) 2 mg
Number of subjects: 288
Study 8295604 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg
Number of subjects: 288
Study 8295604 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of DHE 2 mg and paracetamol 1000 mg
Number of subjects: 288
Study 8295604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study 3815266 — intervention group
Group type: COMPARATOR
Intervention: CFP (Cytoxan, 5-fluorouracil, prednisone)
Number of subjects: 141
Study 3815266 — intervention group
Group type: EXPERIMENTAL
Intervention: CFPMV (Cytoxan, 5-fluorouracil, prednisone, methotrexate, vincristine)
Number of subjects: 141
Study 3815266 — intervention group
Group type: EXPERIMENTAL
Intervention: CA (Cytoxan, Adriamycin)
Number of subjects: 141
Study 30975712 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus advance care planning (ACP)
Number of subjects: 205
Study 30975712 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study 30975712 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus ACP
Number of subjects: 205
Study 30478122 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace smoking cessation group training programme with financial incentives
Number of subjects: 24
Study 26632891 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-locating Wolfram catheter
Number of subjects: 61
Study 26632891 — intervention group
Group type: COMPARATOR
Intervention: Straight Tenckhoff catheter
Number of subjects: 61
Study 24041381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic activation of the irrigant
Number of subjects: 84
Study 24041381 — intervention group
Group type: COMPARATOR
Intervention: Syringe irrigation (control)
Number of subjects: 84
Study 21286740 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS plus ET
Number of subjects: 30
Study 21286740 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS alone
Number of subjects: 30
Study 21286740 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation plus ET
Number of subjects: 30
Study 18176825 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical metronidazole (10 percent)
Number of subjects: 47
Study 18176825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 17342880 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (calcium-phosphate)
Number of subjects: 160
Study 17342880 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (active group)
Number of subjects: 160